Package Leaflet: Information for the User
Gelogrip Powder for Oral Solution
Paracetamol, Phenylephrine, and Chlorphenamine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
|
Contents of the Package Leaflet:
Gelogrip is an association of paracetamol, chlorphenamine, and phenylephrine.
Paracetamol is an analgesic that reduces pain and fever.
Chlorphenamine is an antihistamine that relieves nasal secretion.
Phenylephrine is a sympathomimetic that reduces nasal congestion.
It is indicated in adults for the treatment of symptoms of colds and flu that include fever, mild or moderate pain, congestion, and nasal secretion.
You should consult a doctor if it worsens or does not improve, or if the fever persists for more than 3 days or the pain or other symptoms persist for more than 5 days.
Do not takeGelogrip
Warnings and Precautions
Consult your doctor or pharmacist before starting to take Gelogrip.
You should consult a doctor before taking this medicine:
During treatment with Gelogrip, inform your doctor immediately if:
Children and Adolescents
This medicine is contraindicated in patients under 18 years of age.
Taking Gelogrip with other medicines
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
In particular, if you are using any of the following medicines, it may be necessary to modify the dose of some of them or to interrupt treatment:
Interference with analytical tests:
If you are going to undergo any diagnostic test (including blood tests, urine tests, skin tests that use allergens, etc.), inform your doctor that you are taking/using this medicine, as it may alter the results.
Taking Gelogrip with food, drinks, and alcohol
While taking this medicine, you must not drink alcoholic beverages, as it may increase the appearance of adverse effects of this medicine.
Additionally, the use of medicines containing paracetamol by patients who habitually consume alcohol (3 or more alcoholic beverages: beer, wine, liquor, ... per day) may cause liver damage.
Taking this medicine with food does not affect its efficacy.
Pregnancy, Breast-feeding, and Fertility
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
This medicine should not be taken during pregnancy unless your doctor considers it strictly necessary.
Women who are breast-feeding should not take this medicine, as paracetamol and chlorphenamine pass into breast milk in small amounts, which may cause adverse effects in the baby.
Driving and Using Machines
Gelogrip may cause drowsiness, altering mental and/or physical ability. If you notice these effects, avoid driving vehicles or using machines.
Gelogrip contains sucrose and sodium:
This medicine contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Patients with diabetes mellitus should note that this medicine contains 3.994g of sucrose per sachet.
This medicine contains less than 23mg of sodium (1mmol) per sachet; it is essentially "sodium-free".
Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The recommended dose is:
Adults: 1 sachet every 6-8 hours as needed (three or four times a day). Do not take more than 4 sachets (4 grams of paracetamol) in 24 hours (one day).
Patient with liver failure: These patients can only take 1 sachet every 8-12 hours as needed. They should not take more than 2 sachets in 24 hours.
Patient with kidney failure: These patients must not take this medicine due to the dose of paracetamol.
Use in Children
This medicine is contraindicated in patients under 18 years of age.
Use in Elderly Patients
Elderly patients must not use this medicine without consulting a doctor, as some adverse effects of the medicine, such as slow heartbeats (bradycardia) or reduced cardiac output, due to the content of phenylephrine and chlorphenamine, may especially affect them. They are also more likely to experience adverse effects such as dizziness, sedation, confusion, hypotension, or excitement, and may be more sensitive to effects such as dry mouth and urinary retention.
How to take
Gelogrip sachets are taken ORALLY.
Dissolve the contents of the sachet completely in a little liquid, preferably in half a glass of water, and then drink.
Always take the smallest effective dose.
Taking this medicine is subject to the appearance of symptoms. As they disappear, this medication should be suspended.
If the fever persists for more than 3 days of treatment, the pain or other symptoms persist for more than 5 days, or worsen, or new ones appear, you should consult a doctor.
If you take moreGelogripthan you should
If you have ingested an overdose, you should go quickly to a medical center, even if there are no symptoms, as they often do not appear until 3 days after ingestion of the overdose, even in cases of severe poisoning.
The symptoms of overdose may be: dizziness, vomiting, loss of appetite, yellowing of the skin and eyes (jaundice), abdominal pain, and pancreatitis. Anxiety, fear, agitation, headache (may be a symptom of high blood pressure), convulsions, insomnia (or intense drowsiness), clumsiness, feeling of fainting, instability, confusion, irritability, tremors, anorexia; psychosis with hallucinations (especially in children). Dryness of the mouth, nose, or throat. Effects such as high blood pressure, arrhythmias (rapid or irregular heartbeats), palpitations, reduced urine production. Metabolic acidosis (decrease in blood alkaline reserve). In prolonged use, it can cause plasma volume depletion (decrease in blood volume).
Overdose can also cause: coagulation disorders (blood clots and hemorrhages).
Treatment of an overdose is more effective if started within 4 hours of taking the overdose of the medicine.
Patient being treated with barbiturates or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, Telephone: 91 562 04 20, indicating the medicine and the amount ingested.
Like all medications, Gelogripcan produce adverse effects, although not all people suffer from them.
During the period of use of the association of paracetamol, phenylephrine, and chlorphenamine, the following adverse effects have been reported, whose frequency has not been established with precision:
Discomfort, low blood pressure (hypotension), and increased levels of transaminases in the blood. Myocardial infarction, ventricular arrhythmia (irregular heartbeats), pulmonary edema (increase in lung fluid volume) and cerebral hemorrhage (at high doses or in sensitive patients.
Nervous excitement (generally with high doses and more frequent in the elderly and children), which may include symptoms such as: restlessness, insomnia, nervousness, and even convulsions. Other adverse effects that may appear with low frequency are: chest tightness, lung noises, rapid or irregular heartbeats (generally with overdose), liver disorders (which may present with stomach pain or abdominal pain, dark urine, or other symptoms), allergic reaction, severe hypersensitivity reactions (cough, difficulty swallowing, rapid heartbeats, itching, swelling of eyelids or around the eyes, face, tongue, difficulty breathing, etc.), photosensitivity (sensitivity to sunlight), cross-sensitivity (allergy) to medications related to chlorphenamine. Alterations in blood (changes in the formula of blood cells, such as agranulocytosis, leukopenia, aplastic anemia, thrombocytopenia) with symptoms such as unusual bleeding, sore throat, or fatigue; low or high blood pressure, edema (swelling), alterations in the ears, impotence, menstrual alterations.
Paracetamol may damage the liver when taken in high doses or in prolonged treatments.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30°C.
Medications should not be thrown away through the sewers or in the trash. Deposit the packaging and medications you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition ofGelogrip
Each sachet contains:
Appearance of the Product and Content of the Packaging
Gelogripis a powder for oral solution. It is presented in sachets that are packaged in boxes of 10 units.
Marketing Authorization Holder and Manufacturer
Holder:
Ferrer Internacional S.A.
Gran Vía Carlos III, 94
08028 Barcelona (Spain)
Manufacturer:
Laboratorios ALCALÁ FARMA, S.L.
Avenida de Madrid, 82
28802 Alcalá de Henares
(Madrid)
Date of the Last Revision of this Prospectus:February 2025
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/